SANTHE Collaborative Grants

Collaborate on HIV/AIDS & TB Research

The Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) provides applications from investigators for 1-year collaborative grants for research projects that address critical challenges to African capacity in HIV and/or TB clinical, social/behavioural, and biomedical science. Priority is given to projects that establish new collaborations that add value to existing skills and initiate a programme of study that is likely to be competitive for external funding. Project leadership must include at least one investigator who is based at a *SANTHE site.

Funding Amounts

Up to $50,000 USD in direct costs is available to support each project.  Allowable project expenses include salaries or stipends, travel for research or conference attendance, research materials and supplies, laboratory and office equipment, computer hardware, and software.  All equipment must remain at the African site at the close of the project.

Please allow at least a month for your application to be processed and have the following documentation ready for uploading for proposal submission:

  • CVs of the Principal and co-Principal applicants
  • Three letters of support
  • Budget
  • Budget justification


  • Eligible SANTHE Sites include: UKZN/AHRI (University of KwaZulu-Natal/Africa Health Research Institute); RZHRG (Rwanda Zambia HIV Research Group); KWTRP (KEMRI Wellcome Trust Research Programme); BHP (Botswana Harvard AIDS Institute); the Universities of Nairobi; Botswana; Rwanda; and Zambia; Aurum Health Institute S.A.; UVRI Uganda; and CDC Western Kenya.
  • All project activities must be completed within two years of receipt of funds.
  • Funds will be administered as sub-contracts from the Africa Health Research Institute (Durban, South Africa), and will be payable in Rands or USD.
  • It is anticipated that five collaborative grants will be funded per year. All applications will be reviewed by an expert panel and awarded at the discretion of the SANTHE Consortium Steering Committee.
  • Successful projects will be required to provide written confirmation of appropriate ethics and biosafety approvals (as needed) prior to the transfer of sub-contract funds.
  • Progress reports will be required every 6 months. 

Any queries can be addressed to: